5-CHLOROMETHYL-3-CYCLOBUTYL-[1,2,4]OXADIAZOLE, 95.0%, 100mg

N-benzyl-6-methoxy-1,3-benzothiazol-2-amine, 95.0%, 2.5g

[1-(4-Bromobenzyl)piperidin-4-yl]methanamine dihydrochloride, 95.0%, 1g

5-Methyl-2-(piperidin-4-yloxy)-pyridine hydrochloride, 95.0%, 1g

Ethyl 2-chloro-4-methylpyrimidine-5-carboxylate, 95.0%, 100g

EDTA disodium salt solution, ROTI® volume 0.01 mol/l - 0.01 N, ampoule, 1 piece

H-N-Me-Met-OH, 95.0%, 1g

2-(3-Amino-1-bicyclo[1.1.1]pentanyl)propan-2-ol;hydrochloride, 98%, 1g

6-(Trifluoromethyl)-3-pyridinecarboxaldehyde>98.0%(GC)1g

TGN-020 (sodium), 250mg

2-(Dicyclohexylamino)acetic acid, 95%, 500mg

4-Fluoro-3-nitrobenzenesulfonamide, 95.0%, 100g

trans,trans-4-(3,4-Difluorophenyl)-4'-ethyl-1,1'-bi(cyclohexane), 97%, 100g